Проблема оксида азота в неврологии

Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997; 2:2153-2157.

Hassan H.H., Denis M., Krimbou L. Cellular cholesterol homeostasis in vascular endothelial cells. Can J Cardiol. 2006 Feb; 22 Suppl B:35B-40B.

Hayashi K., Kurokawa J., Nomura S. Effect of fluvastatin sodium (XU 62320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzymeA reductase, on the induction of low-density lipoprotein receptor in HepG2 cells. Bioch. Biophys. Acta, 1993; 30:305-306.

Hayward L.J., Rodriguez J.A., Kim J.W. Et al. // J. Biol. Chem. - 2002. - 277, N 18. - P. 15923-15931.

Hazell A.S. N-acetylcysteine attenuates early induction of heme oxygenase-1 following traumatic braininjury // Brain Res. - 2005. - Vol. 1033. -

P. 13-19.

Hebert R., Brayne C. Epidemiology of vascular dementia // Neuroepidemiol. 1995. Vol. 14. P. 240-257.

Hedin S.G. Uber die bildung von arginin aus proteinkorper. Z Physiol Chem 1895; 21:155168.

Heitzer T., Just H., Munzel T. Antioxidant vitamin С improves endothelial dysfunction in chronic smokers. Circulation, 1996: 94: 6-9.

Heitzer Т., Via Herttuala S., Luoma J. et al. Cigarette smoking potentiates endothelial dislunction of forearm resistance vessels in patients with hypercholes-terolemia. Role of oxidized LDL. Circulation. 1996, 93: 1346-1353.

Hennig L., Andresen D., Hennig A., et al. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia // J Clin Pharmacol 1991;31:636-640.

Herbert J., Goodyer I.M., Grossman A.B., Hastings M.H., de Cloet E.R., Lightman S.L., Lupien S.J., Roozendaal B., Seck J.R. Do corticosteroids damage the brain? // Journal of Neuroendocrinology. - 2006, Vol. 18, P. 393-411.

Herrington D. Role of estrogens, selective estrogen receptor modulators and phytoestrogens in cardiovascular protection. Can J Cardiol 2000; Aug; 16 Suppl E:5E-9E.

Herrsshaft H., Kunze U., Glein F. Die Wirkung von Actovegin anf die Gehinstaffwech sel des menschen // Med Welt. 1977. Bd. 28. S.339-345.

Hershey L.A., Olszewski W.A. Ischemic vascular dementia // In: Handbook of Demented Illnesses. Ed. By J.C. Morris. New York etc.: Marcel Dekker, Inc. 1994. P. 335-351.

Higashi Y., Oshima Т., Orono R. et al. Effect of L-arginine infusion on systemic and renal hemodynamics in hypertensive patients. Am J Hypertens 1999;12:8-15.

Hill M., Takano H., Tang X.L. et al. Nitroglycerin induces late preconditioning against myo-cardial infarction in conscious rabbits despite development of nitrate tolerance // Circulation 2001;104(6):694-699.

Hippisley-Cox J., Cater R., Pringle M. Cross sectional survey of effectiveness of lipid lowering drugs in reducing serum cholesterol concentration in patients in 17 general practices. BMJ, Mar 2003; 326: 689.

Hobbs A.I., Fukuto I.M., Iguarro L.I. // Ibid. 1994. 91. P. 10992-10996.

Hof R.J., Hocking L., Wright P.K., Ralston S.H. Nitric oxide is a mediator of apoptosis in the rheumatoid joint// Rheumatology. - 2000. - Vol. 39, № 9. - P. 1004-1008.

Hogg N., Sing R.J., Konorev E. et al. I.I. Biochem. J. - 1997. - 323, N 2. - P. 477-481.

Hogg N., Kalyanamman B., Joseph J. Inhibition of low-density lipoprotein oxidation by nitric oxide: potential role in atherogenesis. FEBS Lett, 1993; 334: 170-174.

Holm Р., Andersen L., Andersen М., Erhardtsen Е., Stender S. The Direct Antiatherogenic Effect of Estrogen Is Present, Absent, or Reversed, Depending on the State of the Arterial Endothelium A Time Course Study in Cholesterol-Clamped Rabbits Circulation. 1999; 100:1727-1733.

Homing B., Maier V., Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation, 1996; 93: 210-214.

Houston M., Chumley P., Radi R. et al. // Arch. Biochem. Biophys. - 1998. - 355, N1. - P. 1-8.

Huang K.P., Huang F.L. // Biochem. Pharmacol. - 2002. - 64, N 5-6. - P. 1049-1056.

Hulette C.M. Brain banking in the United States // J Neuropathol Exp Neurol. 2003. Vol. 62. N. 7. P. 715-722.

Hulley S., Grady D., Bush T. et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary artery disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998; 280:605-13.

Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America // Circulation 2001; 104(24):2996-3007.

Ibi M. Sawada, H. Nakanishi, M. Kume, T. Katsuki, H. Kaneko, S. Shimohama and Akaike, A. (2001) Neuropharmacol., 40, 761-771.

Ignarro L.J., Cirino G., Casino A. et al. Nitric oxide as a signating molecule in the vascular system: an overview. J Cardiolvasc Pharmacol 1999; 34:879-886.

Ignarro L.J., Napoli C., Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide. Аn overview. Circulat Res 2002; 90:l:21-28.

Ignarro L.J., Byrns R.E., Buga G.M., Wood K.S. Endothelium derived relaxing factor from pulmonary artery and vein possesses pharmaciilogical and chemical properties identical to those of nitric oxide radical. Circul. Research. 1987; 61: 866-879.

Ikeda U. Prevention and early intervention for vascular dementia in community dwelling elderly: Findings from the Nakayama study // Psychogeriatrics. 2003. Vol. 3. P. 17-20.

Ikeda U., Ito T., Shimada K. Statins and C-reactive protein. Lancet 1999; 353:1274-1275.

Induction of nitric oxide synthase by traumatic braininjury // Y. Orihara, K. Ikematsu, R. Tsuda, I. Nakasono // Forensic. Sci. Int. - 2001. - Vol. 123. - P. 142-149.

Insull W., Black D., Dujovne С. et al. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia. Arch. Intern. Med., 1994; 154:2449-2455.

Iqbal K., Winblad B., Nishimura T., Takeda M., Wisniewski(eds) H.M. Alzheimer's Disease: Biology, Diagnosis and Therapeutics John Willey and Sons Ltd. 1997. 830 p.

Irani K. Oxidant signaling in vascular cell growth, death and survival. Circulat Res 2000;87:179-190.

Ischiropoulos H., Zhu L., Chen J. et al. // Arch. Biochem Biophys. - 1992. - 298, N 3. -P. 431-437.

Ischiropoulos H. // Arch. Biochem. Biophys. - 1998. - 356, N 1. -

P. 1-11.

ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction // Lancet 1995; 345:669-685.

Itoh Т., Matsuya Y., Maeta H. et al.. // Chem. Pharm. Bull. - 1999. - 47, N 1. - P. 133-135.

Jaffe R., Ariel I.; Beeri R., Paltiel O., Hiss Y., Rosen S., Brezis M. 1997 Exp. Nephrol. 5, 399-403.

Jancovic J. Theories on the ethiology and pathogenesis of Parkinson's disease // Neurology. 1992. V. 42. P. 21-23.

Jaranowska A. et al. Molec. Chem Neuropath. - N2.-P.95-106.-1995.

Jay M.T., Chirieo S., Siow R.C. et al. Modulation of vascular tone by low-density lipoproteins: effect on L-arginine transport and nitric oxide synthesis. Exp Physiol 1997; 82:349-360.

Jean-Baptiste Michel Nitric oxide and Cardiovascular Homeostasis 1999 Menarini International Industrie Farmaceutiche Riunite s.r.l. Paris.

Jelic V., Winblad B. Treatment of mild cognitive impairment: rationale, present and future strategies // Acta Neurol. Scand. 2003. Vol. 107 (Suppl. 179). P. 83-93.

Jellinger K.A. Pathology of parkinsonism / Recent Developments in Parkinson's Disease. New York: Raven Press, 1986. P. 33-36.

Jensen-Urstad K.J., Reichard P.G., Rosfors J.S. et al. Early atherosclerosis is retarded by improved long-term blood-glucose control in patients with IDDM. Diabetes, 1996; 45: 1253-1258.

Jeremy R., McCarron N., Sulivan D. Effect of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilatation in the hypercholesterolemic rabbit: response according to treatment duration, anatomic site and sex. Circulation 1996; 94:488-506.

Jesberger J.A., Richardson J.S. (1991) Oxygen free radicals and brain dysfunction. Int. J. Neurosci., 57(1-2): 1-17.

Jia Z., Bonaventura C., Bonaventura J., Stamler J.S. // Nature. - 1996. - 380, N 6571. - P. 221-226.

Jia Z. and Nimere, I. (1999) Steroids, 64, 541-550.

Joannides R., Haefeli W.E., Linder L. et al. Nitric oxide is responsible for flow-dependent dilation of human peripheral conduit arteries in vivo. Circulation, 1995: 91: 1314-1319.

Jocubaitis L. Updated clinical experience with fluvastatin. Am J Cardiol 1994; 73:18-24.

Johnson A., Mackway-Jones K. Frusemide or nitrates in acute left ventricular failure // Emerg Med J 2001; 18:59-60.

Johnstone M.T. Creager S.L., Scales K.M. et al. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation, 1993; 88: 2510-2516.

Jorm A.F., Korten A.E., Henredson A.S. The prevalence of dementia: A quantitative integration of the literature // Acta Psychiatr. Scand. 1987. Vol. 76.

P. 465-479.

Jourd'heueil D., Hallen K., Feelisch M., Grisham M.В. Dynamik state of S-nitrosothiols in human plasma and whole blood. Free Radic Biol Med - 2000. - 28, N 3. - P. 409-417.

Jourd'heuil D., Kang D., Grisham M.B. // Frontiers in Bioscience. - 1997. - 2. - P. dl89-dl96.

Jugdutt B.I., Khan M.I., Jugdutt S.J. et al. Impact of left ventricular unloading after late reperfusion of canine anterior myocardial infarction on remodeling and function using isosorbide-5-mononitrate // Circulation 1995; 92:926-934.

Jugdutt B.I., Warnica J.W. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion and complication: effect of timing, dosage and infarct location // Circulation 1988; 78:906-919.

Junquero D.C., Schini V.B., Vanhoutte P.M. Indapamide potentiates the endothelium-dependent production of cyclic guanosine monophosphate by bradykinin in the canine femoral artery. Am Heart J 1991 Oct; 122 (4 Pt 2):1204-9.

Kaasjager K.A., Koomans H.A., Rabelink T.J. (1997) Endothelin-1 induced vasopressor responses in essential hypertension. Hypertension,

30(1 Pt 1): 15-21.

Kagami S., Border W.A., Miller D.A., Nohle N.A. Angiotensin II stimulates extracellular matrix protein syntliesis through induction ot transforming growth factor В in rat glomerular mesangial cells. J. Clin. Invest, 1994: 93:2431-2437.

Kagiyama S., Tsuchihashi Т., Abe I., Fujishima M. Cardiovascular effects of nitric oxide in the rostral ventrolateral medulla of rats// Brain Res. - 1997. - 757. - P.155-158.

Kalueff A.V., K.O. Eremin, Tuohimaa P., Kamal E., Habib M.D., Philip W., Gold M.D., George P. Chrousos. Neuroendocrinology of stress //Endocrinology and Metabolism Clinics. - Vol. 30 - №3, 2001. - Р. 695-728.

Kamei Y., Kawada T., Fukuwatori T., Ono T., Kato S. and Sugimoto, E. (1995) Gene, 152, 281-282.

Kanowsky S., Kinzler E., Lehman E. et al. Confirmed clinical efficacy of actovegin in elderly patients with organic brain syndrome // Pharmacopsychiat. 1995. V. 28. P. 125-133.

Kaplan K.D.R., Parker M., Przybylek J. et al. Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy // Am J Cardiol 1983; 51:694-698.

Kaplan N.M. The ASCOT trial: a closer look. J Hypertens. 2006 Feb; 24(2):211-4.

Kari J.A., Donald A.T., Vallance D.T. et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Intern 1997; 52:468-472.

Kaski J.C., Plaza L.R., Meran D.O., et al. Improved coronary supply: prevailing mechanism of action of nitrates in chronic stable angina // Am Heart J 1985; 110:238-245.

Kataoka H., Otsuka F., Ogura T., Yamauchi T., Kishida M., Takahashi M., Mimura Y., Makino The role of nitric oxide and the rennin-angiotensin system in salt-restricted Dahl rats. H Am J Hypertens 2001 Mar; 14(3):276-85.

Katayama Y. // Dojindo Newsletter. - 1995. -N 1. - P. 1-36.

Katsuki H. & Okuda S. 1995 Prog. Neurobiol. 46, 607-636.

Katz R.J., Levy W.S., Buff L. et al. Prevention of nitrate tolerance with angiotensin converting enzyme inhibitors // Circulation 1991; 83:1271-1277.

Katzenschlager R., Lees A.J. Treatment of Parkinson's disease: levodopa as the first choice // J Neurol. 2002. V. 249 [Suppl 2]. P. II/19-II/24.

Kaushik P.Patel, Yi-Fan Li, Yoshkitaka Hirooka. Role of Nitric Oxide in Central Sympathetic Outflow // Experimental Biology and Medicine. 2001; 26, Р. 814-824.

Kavanagh B.P., Pearl R.G. // Int. Anestesiol. Clin. - 1995. - Vol. 33. - P. 181-210.

Kavanaugh W.M., Williams L.T. Science, 1994, 266. - P.1862-1865.

Kazuhiro S., Michel T. (1997) Expression and regulation of endothelial nitric oxide synthase. TCM, 7(1): 28-37.

Ke J.P., Low N.O. and atherogenesis. PNAS 2003; 100:3:768-770.

Kearney D., Fitzgerald D. The anti-thrombotic effects of statins. J Am Coll Cardiol 1999; 33:1305-7.

Keese M.A., Bose M., Mulsch A. et al. //Biochem. Pharmacol. - 1997. - 54, N 12. - P. 1307-1313.

Keller J.N., Schmitt F.A., Scheff S.W. et al. Evidence of increased oxidative damage in subjects with mild cognitive impairment // Neurology. 2005. Vol. 64. P. 1152-1156.

Kharitonov S.A., Alving K., Barnes P.J. Exhaled and nasal nitric oxide measurements: recommendations // Eur. Resp. J. -1997. - Vol. 10. - P. 1683-1693.

Kidd G.A., Dobrick L.W., Brovkovych V. et al. Nitric oxide deficiency contributes to large cerebral infarct size. Hypertension 2000;35:1111-1118.

Kiechle F.L., Malinski T. // Amer. J. Clin. Pathol. - 1993. - Vol. 100. - P. 567-575.

Kielstein J.T., Bode-Boger S.M., Haller H. et al. Functional changes in ageing kidney: is there a role for asymmetric dimethylarginine? Nephrol Dial Transplant 2003; 18:7:1245-1248.

Kim Y.M., Bergenia H.A., Muller С, Р.I.В. R. et al. // J. Biol. Chem. - 1995. - 270, N 11. - P. 5710-5713.

Kimura M., Kurose I., Russell J. et al. Effects of fluvastatin on leukocyte- endothelial cell adhesion in hypercholesterolemic rats. Arterioscler Thromb Vasc Biol 1997; 17:1521-6.

Kingwell B.A. Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease. FASEB J 2000 Sep; 14(12):1685-96.

Kishi Y., Watanabe T., Makita T., Sakita S., Watanabe R., Ashikaga T., Numano F. Effect of nifedipine on cyclic GMP turnover in cultured coronary smooth muscle cells. J Cardiovasc Pharmacol. 1995; 26:590-595.

Kiеlstein J., Bode-Boger Т., Frolich J.С. et al. Asymmetric dimethylarginine, blood pressure and renal perfusion in elderly subjects. Circulation 2003;107, V. 14:1891-1895.

Klahr S., Morrissey J. Angiotensin II and gene expression in the kidney // Am. J. Kidney Dis. - 1998. - Vol. 31. - №1. - Р. 171-176.

Klang O., Rolstad S., Nordlung A. Mild Cognitive Impairment of primary and vascular aetiology: differences in episodic memory? // 2nd Congress of the International Society for Vascular Behavioural and Cognitive Disorders (Vas-Cog). Abstract book. Florence, 2005. P. 48-49.

Klatt P., Schmidt K., Uray G., Mayer B. 11 J. Biol. Chem. 1993. 268. P. 14781-14784.

Kleemann R., Kooistra T. HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol. Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec; 5(6):441-453.

Kleinert H., Wallerath Т., Euchenhofer С. et al. Ulrich Forstermann Estrogens Increase Transcription of the Human Endothelial NO Synthase Gene Analysis of the Transcription Factors Involved Hypertension. 1998; 31:582-588.

Kleschov A.L., Hubert G., Munzel T. et al. // BMC Pharmacology. - 2002 http://www. Biomedcentral. Com/1471-2210/2/3.

Kleschyov A.L., Muller В., Keravis T. et al. // Am. J. Physiol. Heart Circ. Physiol. - 2000. -279, N 6. - P. H2743-H2751.

Kloner R.A., Shook T., Przyklenk K., et al. Previous angina alters in-hospital outcome in TIMI 4: a clinical correlate to preconditioning? // Circulation 1995; 91:37-47.

Kluge I., Gutteck-Amsler U., Zollinger M., Do KQ. S-nitrosoglutathione in rat cerebellum: identification and quantification by liquid chromatography-mass spectrometry. J Neurochem 1997; 69: 2599-607.

Knowles R.G., Moncada S. I I Trends Biochem. Sci. 1993. 17, N 10. P. 399-402.

Koizumi J., Haraki T., Kunimaza Y. et al. Clinical efficacy of fluvastatin in the long-term treatment of familial hypercholesterolemia. Am J Cardiol 1995; 76:47-50.

Kojda Т., Harrison D. Interaction between NO and reactive oxigen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart Failure. Cardiovasc Res 1999; 43:562-571.

Kolpakov V., Gordon D., Kulik T.J. Nitric oxide-generating compounds inhibit total protein and collgen synthesis in cultured vascular smooth cells. Circul. Res. 1995; 76: 305-309.

Konijn A.M., Glickstein H., Vaisman B. et al. //Blood. - 1999. - 94, N 6. - P. 2128-2134.

Koppenol W.H.B. Quim. Nova. - 1998. - 21, N 3. - P. 326-331.

Kou V., Nassisi D. Unstable angina and non-ST-segment myocardial infarction: an evidence-based approach to management // Mt Sinai J Med 2006; 73:449-468.

Krenek P., Salomone S., Kyselovic J., Wibo M., Morel N., Godfraind T. Lacidipine Prevents Endothelial Dysfunction in Salt-Loaded Stroke-Prone Hypertensive Rats. Hypertension 2001; 37: 1124-1128.

Kroncke K.D., Klotz L.O., Suschek C.V. and Sies, H. (2002) J. Biol. Chem., 277, 13294-13301.

Kruszewski M., Iwanenko T. // Acta Biochim. Pol. - 2003. - 50, N 1. - P. 211-215.

Kubes P., Granger D.N. Nitric oxide modulates microvascular permeability. Amer. J. Physiol. 1992; 262: H611-H615.

Kubes P., Suzuki M., Granger D.N. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA., 1991; 88:4651-4655.

Kuller L.H., Matthews K.A., Sutton-Tyrrel K. et al. Coronary and aortic calcification among women 8 years after menopause and their premenopausal risk factors: the healthy women study. Artherioscler. Thromb. Vasc. Biol. 1999; 19:2189-2198.

Kumor V., M. Calach. Treatment of Alzheimer's disease with cholinergic drugs // Int J Clin Pharm Ther Toxicol. 1991. V. 29. № 1. P. 23-37.

Kurioka S., Koshimura K., Sugitani M. et al. Analysis of urinary nitric oxide metabolites in healthy subjects // Endocr.J. - 1999. - Vol. 46, № 3. -

P. 421-428.

Kwak B.R., Mach F. Statins inhibit leukocyte recruitment-new evidence for their anti-inflammatory properties. Arterioscler Thromb Biol 2001; 21:1256-1258.

Lacoste L.L., Theroux P., Lidon R.M. et al. Antithrombotic properties of transdermal nitro-glycerin in stable angina pectoris // Am J Cardiol 1994; 73(15):1058-1062.

Lancaster J.R. Jr. // Proc. Natl. Acad. Sci. USA. - 1994. - 91, N 15. - P. 8137-8141.

Langham J., Goldfrad C., Teasdale G., Shaw D., Rowan K. (2000). Cochrane Database Syst Rev 2000; (2): CD000565.

Langub, M.C., Herman, J.P., Malluche, H.H., and Koszewski, N.J. (2001) Neurosci., 104, 49-56.

Lanzino G, Kassell NF, Dorsch NW, Pasqualin A, Brandt L, Schmiedek P, Truskowski LL, Alves WM. J Neurosurg 1999 Jun; 90(6):1011-7.

LaRosa J.C., Jiang H., Vupputuri S. Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials. JAMA, Dec 1999; 282:2340-2346.

Larrabee G.J., Crook T. M. Estimated prevalence of age associated memory impairment derived from standardized tests of memory function // Int Psychogeriatr. 1994. V. 6. N.1. P. 95-104.

Larrat E.P. Cost-effectiveness study of nitrate therapy using a decision analysis methodology // Hosp Formul 1994; 29(4):277-278.

Lasher T.F. Angiotensin, ACE-inhibitors and endothelial control of vasomotor tone. Basic Research. Cardiol. 1993; 88(SI): 15-24.

Latini R., Staszewsky L., Maggioni A.P. et al. Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the Delapril Remodeling after Acute Myocardial Infarction (DRAMI) trial. Am Heart J 2003; 146(1):133-141.

Laufs U., Fata V., Plutzky О. et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97:1129-35.

Law M., Wald N.J. Efficacy and safety of cholesterol-lowering treatment. Lancet 2006 Feb 11; 367(9509):469-70.

Lee S.H., Soyoola E., Chanmugam P., Hart S., Sun W., Zhong H., Liou S., Simmons D. & Hwang D.(1992 J. Biol. Chem. 267, 25934-25938.

Lees K.R; Asplund K.; Carolei A.; Davis S.M.; Diener H.C.; Kaste M.; Orgogozo J.M.; Whitehead J. Lancet. 2000 Aug 12; 356(9229):597; Lancet. 2000 Jun 3; 355(9219):1925-6.

Lefer A.M. Nitric oxide: Nature's naturally occuring leukocyte inhibitor. Circulation, 1997; 95: 553-554.

Lefer D.J., Scalia R., Jones S.P. et al. HMG-CoA reductase inhibition protects the diabetic myocardium from ischemiareperfusion injury. FASEB J 2001; 15:1454-1456.

Leone A.M., Gusiafsson L.E., Francis L.P. Nitric oxide is present in exhaled breath in humans: Direct GC-MS confirmation // Biochem. Biophys. Res. Com. - 1994. - Vol. 201. - P. 883-887.

Leppert D., Waubaunt Ј., Galardy R. et al. T-cell gelatinases mediate basement membrane transmigration in vitro // J. Immunol. - 1995. - Vol. 154. - P. 4379-4389.

Lerman A., Burnett J.С., Higano S.T. et al. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 1998; 97:2123-2128.

Leu H.B., Chen J.W., Wu T.C. et al. Effects of fluvastatin, an HMG-CoA reductase inhibitor, on serum levels of interleukin-18 and matrix metalloproteinase-9 in patients with hypercholesterolemia. Clin Cardiol. 2005 Sep; 28(9):423-8.

Levine G.V., Erei B., Koulouris S.N. et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery discase. Circulation 1996; 93: 1107-1113.

Levy R. Aging-associated cognitive decline // Int Psychogeriatr. 1994. V. 6. P. 63-68.

Lewis B.S., Rabinowitz B., Schlesinger Z., et al. Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study // Cardiology 1999; 91(1):1-7.

Lezak M.D. Neuropsychology assessment // N.Y. University Press. 1983. P. 768.

Li G.L., Farooque M., Holtz A., Olsson Y. (1999) Acta Neuropathol. (Berl) 98, 473-480.

Li H. Nitric oxide in the patogenesis of vascular disease / H. Li, U. Forstermann // J. Pathol. 2000. Vol. 190(3). P. 244-254.

Li H., Meininger C.J., Hawker J.R. et al. Regulatory role of arginase I and II in nitric oxide, polyamine and proline synthesis in endothelial cells. Am J Physiol Endocrinol Metab 2001; 280:E75-E82.

Li Y.C., Pirro A.E. and Demay M.B. (1998) Endocrinol., 139, 847-851.

Liao J.K. Clinical implications for statin pleiotropy. Curr Opin Lipidol. 2005 Dec; 16(6):624-629.

Liao J.К. Endothelium and acute coronary syndromes. Clin Chem 1998; 44:1799-1808.

Lin K.Y., Ito A., Asagami T. et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine dimethylaminohydrolase. Circulation 2002; 106:987-992.

Lin A.M., Fan S.F., Yang D.M., Hsu L.L. and Yang C.H. (2003) Free Radic. Biol. Med., 34, 1416-1425.

Lipton S.A., Rosenberg P.A. 1994. N Engl J Med 330: 613-622.

Little W.C., Constantinescu M., Applegate R.G. et al. Can coronary angiography predict the site of subsequent myocardial infarction in patients with mils-to-moderatecoronary disease? Circulation 1988: 78: 1157-1166.

Littler W.A., Sheridan D.J. Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group // Br Heart J 1995; 73:428-433.

Liu X., Miller M. J. S., Joshi M.S. et al. // Proc. Natl. Acad. Sci. USA. - 1998. - 95, N 5. - P. 2175-2179.

Liu Z., Rudd M.A., Freedman J.E., Loscalzo J. S-Transnitrosation Reactions Are Involved in the Metabolic Fate and Biological Actions of Nitric Oxide. J pharmacol experiment ther 1998; 284 (2): 526-34.

Losel R. and Wehling, M. (2003) J. Steroid Biochem. Mol. Biol., 83, 167-171.

Losel R. and Wehling M. (2003) Nature Revs Mol. Cell Biol., 4, 46-55.

Lovenstone S., Gauthier S. Management of dementia // London: Martin Dunitz. 2001.

Lowenstein C.J., Dinerman J.L., Snyder S.H. // Ann. Intern. Med. - 1994. - Vol. 120, N 3. - P. 227-237.

Ludmer P.L., Selwyn A.P., Shook T.L. et al. Paradoxical vasoconstriction induced by acetylcholin in athero-sclerotic coronary arteries. New Engl. J. Med. 1986, 315: 1046-1051.

Luscher T.F. (Endothelial dysfunction as a therapeutic target) The ENCORE trials Euuropean Heart J Supplements 2000; 2 (Supplement D), D20-25.

Luscher T.F., Barton M. (1997) Biology of the endothelium. Clin. Cardiol., 20 (11 Suppl. 2): 3-10.

Lymar S.V., Hurst J.К. // J. Am. Chem. Soc. - 1995. - 117. - P. 8867-8868.

Mahmarian J.J., MoyО L.A., Chinoy D.A. et al. Transdermal nitroglycerin patch therapy im-proves left ventricular function and prevents remodeling after acute myocardial infarction: re-sults of a multicenter prospective randomized, double-blind, placebo-controlled trial // Circulation 1998; 97:2017-2024.

Mallis R.J, Buss J.E, Thomas J.A. // Oxidative modification of H-ras: S-thiolation and S-nitrosilation of reactive cysteines. Biochem. J. - 2001. - 355, N 1. - P. 145-153.

Mancini G.D.J., Henry G.C., Macaya С. et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND study. Circulation 1996; 94:258-265.

Mannick J.B., Hausladen A., Liu L. et al. Fas-induced caspase denitrosylation. Science 1999; 284: 651-4.

Stamler J.S. Redox signaling: nitrosylation and related target interactions oi nitric oxide. Cell, 1994; 74: 931-938.

Stamler J.S., Jia L., Eu J.P. et al // Science. - 1997. - 276, N 5321. - P. 2034-2037.

Stampfer M.J., Colditz G.A., Willett W.C. et al Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses'Health Study. N Engl J Med.1991; 325:756-762.

St-Arnaud, R. (1999) Bone, 25, 127-129.

Stefano G., Prevot V., Beauvillain J.C. et al. Cell-Surface Estrogen Receptors Mediate Calcium-Dependent Nitric Oxide Release in Human Endothelia. Circulation. 2000; 101:1594.

Steinberg H.О., Chaker H., Leaning R. Obesity and insulin resistance are associated with endothelial dysfunction. Implication for the syndrome of insulin resistance. J Clin Invest 1996; 97:11:2601-2610.

Steinberg О., Chaker H., Leaning R. Obesity and insulin resistance are associated with endothelial dysfunction. Implication for the syndrome of insulin resistance. J Clin Invest 1996; 97:2601-2610.

Steinhorn R.N., Russell I.A., Morln F.C Pulmonary arteries from newborn lambs with persistent pulmonary hypertension have decreased sensitivity to nitric oxide. Pediat Res 1994; 35:354A.

Stephens S., Kenny R.A., Rowan E. et al. Association between mild vascular cognitive impairment and impaired activities of daily living in older stroke survivors without dementia // J. Amer. Ger. Soc. 2005. Vol. 53. № .1. P. 103-107.

Stephens S., Sadler S., Rowan E. et al. Vascular mild cognitive impairment and cognitive impairment after stroke // Cerebrovascular Disease, Cognitive Impairment and Dementia. Second edition. Ed. By J.O'Brien et al. London, New York: Martin Dunitz, 2004. P. 225-236.

Stephenson D., Rash K., Smalstig B., Roberts E., Johnstone E., Sharp J., Panetta J., Little S., Kramer R., Clemens J. Glia 1999 Aug;27(2):110-28.

Sternberg E.M. Interactions between the immune and neuroendocrine systems. In: Mayer E.A., Saper C.B. Progress in Brain Research. Vol. 122. Elsevier Science. 2000; Р. 328-348.

Stieg P.E., Sathi S., Warach S. et al. Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat // Eur. J. Pharmacol. 1999. Vol. 375.

P. 115-120.

Stoll M., Steckelings M., Paul M., Bottari S.R., Metzger R., Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J.Clin. Invest.1995; 95: 651-657.

Stroes E. Statins and LDL-cholesterol lowering: an overview. Curr Med Res Opin. 2005; 21 Suppl 6:S9-16.

Stroes E.S., Koomans Н.А., de Bmin T.W.A., Rabelink T.J. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet, 1995; 346:467-471.

Stuart J. Hutchison; Krishnankutty Sudhir; Richard E. Sievers; Bo-Qing Zhu;Yi-Ping Sun; Tony M. Chou; Kanu Chatterjee; Prakash C. Deedwania; John P. Cooke; Stanton A. Glantz; William W. Parmley Effects of L-Arginine on Atherogenesis and Endothelial Dysfunction due to Secondhand Smoke Hypertension 1999; 34:44-50.

Stuhlinger M.C., Oka R.K., Graf E.E. et al. Endothelial dysfunction induced by hyperhomocysteinemia: role of asymmetric dimethylarginine. Circulation 2003; 108:933-938.

Sugiama S., Okada Y., Sukhova G.K. et al. // Am. J. Pathol. 2001.

Vol. 158. P. 879-891.

Susie D., Francischetti A., Frohlich E.D. Prolonged L-arginine on cardiovascular mass and myocardial hemodynamics and collagen in aged spontaneously hypertensive rats and normal rats. Hypertension 1999; 33:451-455.

Sussex B.A., Campbell N.R., Raju M.K., McKay D.W. The antianginal efficacy of isosorbide dinitrate therapy is maintained during diuretic treatment // Clin Pharmacol Ther 1994; 56:229-234.

Sutherland M.K., Somerville M.J., Yoong L.K., Bergeron C., Haussler M.R. and McLachlan D.R. (1992) Brain Res. Mol. Brain Res., 13, 239-250.

Sutton M.G., Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy // Circulation 2000; 101:2981-2988.

Swindell A.C., Valentine J.J. Effects of doxazosin on diet-induced hypercholesterolemia in C57BR/cdJ mice. Am J Cardiol 1987 May 29; 59 (14):29G-34G.

Taddei S., Virdis A., Ghiadoni L., Uleri S., Magagna A., Salvetti S. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients. Hypertension. 1997; 30:1606-1612.

Taddei S., Virdis A., Mattel P. et al. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 94:1296-1303.

Takase H., Moreau P., Kung C.F., Nava E., Luscher T.F. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril. Hypertension 1996; 27:25-31.

Takenaka I., Ogata M., Koga K., Matsumoto T., Shigematsu A. Anesthesiology 1994 Feb; 80(2):402-8. Related Articles, Books.

Takizawa S., Fujita H., Ogawa S. et al. Cerebr Blood Flow Metab., 1996, 16. - P.1075-1078.

Takizawa T., Tada T., Kitazawa K., Tanaka Y., Hongo K., Kameko M., Uemura K.I. Neurol Res 2001 Oct; 23(7):724-730.

Talman W.T. // Braz. J. Med. Biol. Res. - 1997. - ЗО, N 4. - P. 515-520.

Tarry W.C., Makhoul R.G. L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty. Arterioscler. Thromb. 1994:14:938-943.

Tawakol A., Ornland T., Gerhard M. et al. Hyperhomocysteinemia is associated with impaired enaothcliurn - dependent vasodilation function in humans. Circulation, 1997:95:1119-1121.

Taylor T., Chasseaud L.F., Doyle E. Pharmacokinetics of isosorbide dinitrate after intravenous infusion in human subjects // Biopharm Drugs Dispos 1980; 1:149-156.

Teo K.K., Catellier D.J. Long-term nitrate use in chronic coronary artery disease: need for a randomized con-trolled trial // Am Heart J 1999; 138(3 Pt 1):400-402.

Thadani U. Oral nitrates: more than symptomatic therapy in coronary heart disease? // Cardiovasc Drugs Ther 1977; 11:213-218.

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial // Lancet 999; 353:9-13.

The Multicenter Diltiazem Post-infarction Trial Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction // N Engl J Med 1988; 319:385-392.

The Parkinson Study Group. Levodopa and the progression of Parkinson's disease // N Engl J Med. 2004. V. 351. P. 2498-2508.

Thiel V.E., Audus K.L. Antioxid Redox Signal 2001 Apr; 3(2):273-278.

Thomas D.D., Liu X., Kantrow S.P., Lancaster J.R.Jr. // Proc. Natl. Acad. Sci. USA. - 2001. - P. 355-360.

Thomas Heitzer, Seppo Yla-Herttuala, Jukka Luoma, Sabine Kurz, Thomas Munzel, Hanjorg Just, Manfred Olschewski, Helmut Drexler Cigarette Smoking Potentiates Endothelial Dysfunction of Forearm Resistance Vessels in Patients With Hypercholesterolemia Role of Oxidized LDL Circulation 1996; 93:1346-1353.

Thomas J.A. Protein S-thiolation, S-nitrosylation, and irreversible sulfhydryloxidation: roles in redox regulation / http: //www.bb.iastate.edu/~bb404/proteinoxidation.pdf.

Thomson L., Trujillo M., Telleri R., Radi R. Kinetics of cytochrome oxidation by peroxynitrite: implications for superoxide measurements in nitric oxide producing biological systems. Arch Biochem Biophys 1995; 319:491-497.

Tien M., Berlett B.S., Levine R.L. еt al. // Biochemistry. - 1999. - 96, N 14. - P. 7809-7814.

Tienfenhacher C.P., Chilian W.M., Mitchel M., DeFily D.V. Restoration of endothclium-dependent vasodilation after reperliision injury by tetrahydrobiopterin. Circulation, 1996: 94: 1423-1429.

Ting H.H., Timimi F.K., Haley E.A., Roddy M.A. et al. Vitamin С improves endothelium-dependent vasodilation in forearm vessels of humans with hypercholes-terolemia. Circulation, 1997: 95: 2617-2622.

Ting H.H., Timini F.K., Boles K.S. el al. Vitamin С improves enoothelium-dependent vasodilatiiin in patients with non-insulin-dependent diabetes mellitus. J. Clin. Investig. 1996: 97: 22-28.

Tingberg E., Roijer A., Thilen U. et al. Randomized, double-blind, placebo-controlled long-term study of isosor-bide-5-mononitrate therapy in patients with left ventricular dysfunction after acute myocardial infarction // Am Heart J. 2003; 145(1):E1.

Tirilazad for acute ischaemic stroke (Cochrane Review). Cochrane Database Syst Rev 2001; 4:CD002087.

Tohru Fukai, Martin R. Siegfried, Masuko Ushio-Fukai, Yian Cheng, Georg Kojda and David G. Harrison Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training J Clin Invest, June 2000, Volume 105, Number 11, 1631-1639.

Tommasino C., Picozzi P. Minerva Anestesiol 1998 May;

64(5):225-227.

Tomomi G., Masataka M. Nitric oxide and endoplasmic reticulum stress // Arteriosclerosis, Thrombosis and Vascular Biology. 2006; 26, Р. 1439.

Tonkin A.M. Clinical relevance of statins: their role in secondary prevention. Atheroscler Suppl. 2001 Feb; 2(1):21-25.

Topol E.J. Intensive statin therapy - a sea change in cardiovascular prevention. N Engl J Med. 2004 Apr 8; 350(15):1562-1564.

Tousoulis D., Davies G.J., Tentolouris С. et al. Effect of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries. Heart 2003; 89:5:531-534.

Touys R.M. Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep 2000; 2:98-105.

Touzani O., Young A.R., MacKenzie E.T. (1994). In: Kriegistein J., Oberpichler-Schwenk H., eds. Pharmacology of Cerebral Ischaemia. Stuttgart: Medpharm, 575-588.

Treasure C.B., Manoukian S.V., Klem J.L. еt al. Epicardial coronary artery response to acetylclioline are impared in hypertensive patients. Circ. Research 1992; 71: 776-781.

Trischler H.J., Wolff S.P. Thioctic (Lipoic)-acid: A therapeutic metalchelating antioxidant? // Biochem.-Pharmacol. - 1995. -Vol. 15. - P. 320-333.

Trujillo M., Alvarez M.K, Peluffo G. еt al // J. Biol. Chem. - 1998. - 273, N 14. - P. 7828-7834.

Trujillo M., Radi R. //Arch. Biochem. Biophys. - 2002. - 397, N 1. - P. 91-98.

Tsao P.S., Wang B., Buitrago R., Shyy J.Y., Cooke J.P. Nitric oxide regulates monocyte chemotactic protein-1. Circulation. 1997; 97: 934-940.

Tschuggel W., Schneeberger C., Unfried G. еt al. Elevation of inducible nitric oxide synthase activity in human endometrium during menstruation // Biol. Reprod. - 1999. - Vol. 60, № 2. - P. 297-304.

Tseng C.J., Liu H.J., Lin H.C. et al. Cardiovascular effects of nitric oxide in the stem nuclei of rats// Hypertension. - 1996. - 27. - P. 36-42.

Tsikas D., Frolich J.С. I I Circ. Res. - 2002. - 90, N 3. - P. e39-e39.

Turko I.V., Murad F. // Farmacol. Rev. - 2002. - 54, N 4. - P. 619-634.

Tzeng E., Billiar T.R. // Arch. Surg. - 1997. - Vol. 132. -P. 977-982.

Tzourio C., Andersen C., Chapman N. et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease // Arch Inern Med. 2003. V. 163. N. 9. P. 1069-1075.

Uffelen B.E.V., Van der Zee J., Roster В.M. et al. // Biochem. J. - 1998. - 330, N 4. -P. 719-722.

Ulfendahl H.R., Aurell M. Renin-Angiotensin/ Portland Press/ London. 1998. Р. 305.

Ulker S., McKeown P.P., Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activity. Hypertension 2003; 41:3:534-539.

Upchurh G.R., Welch G.N., Fabian A.J. et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997; 272:17012-17017.

Uribe R.M., Lee S., Rivier С. Endotoxin stimulates nitric oxide production in the paraventricular nucleus of the hypothalamus through nitric oxide synthase. Correlation with hypothalamo-pituitary-adrenal axis activation // Endocrinology. - 1999. - Vol. 140. - P. 5971-5981.

Размещено на Allbest.ru

...